Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6166202 | 0.91 | LMNA (0.40) | P2RY12 | |
| SCHEMBL6166994 | 0.90 | KDM4E (0.46) | P2RY12 | |
| SCHEMBL6166739 | 0.86 | CHRM2 (0.37) | P2RY12 | |
| SCHEMBL6165806 | 0.82 | HSD11B1 (0.42) | HPGDS | |
| SCHEMBL6169344 | 0.81 | DAGLA (0.41) | P2RY12 | |
| SCHEMBL2316739 | 0.81 | ALDH1A1 (0.47) | P2RY12HPGDS | |
| SCHEMBL6165607 | 0.81 | HRH2 (0.45) | P2RY12 | |
| SCHEMBL6167911 | 0.80 | L3MBTL1 (0.37) | P2RY12 | |
| SCHEMBL6167825 | 0.80 | ALDH1A1 (0.54) | P2RY12 | |
| SCHEMBL6164853 | 0.80 | HTT (0.46) | P2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1349850-B1 | SODIUM CHANNEL MODULATORS DERIVED FROM 2-PIPERIDYLIMIDAZOLES | SOD CONSEILS RECH APPLIC (FR) | 2005-09-07 | — | — | EP | claimed |
| US-20040077640-A1 | Sodium channel modulators derived from 2-piperidylimidazoles | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077640-A1 | Sodium channel modulators derived from 2-piperidylimidazoles | KCNH1, HCN4, KCNH2 | P2RY12 248/4885HPGDS 3832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.